Biodesix Stock Cash And Equivalents

BDSX Stock

USD 1.47 0.10 6.37%

Biodesix fundamentals help investors to digest information that contributes to Biodesix's financial success or failures. It also enables traders to predict the movement of Biodesix Stock. The fundamental analysis module provides a way to measure Biodesix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biodesix stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Biodesix Company Cash And Equivalents Analysis

Biodesix's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Cash

Bank Deposits

+

Liquidities

More About Cash And Equivalents | All Equity Analysis

Current Biodesix Cash And Equivalents

15.18 M

Most of Biodesix's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biodesix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Biodesix Cash And Equivalents Driver Correlations

Understanding the fundamental principles of building solid financial models for Biodesix is extremely important. It helps to project a fair market value of Biodesix Stock properly, considering its historical fundamentals such as Cash And Equivalents. Since Biodesix's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Biodesix's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Biodesix's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Intangible Assets	Common Stock	Property Plant Equipment	Short Long Term Debt	Short Term Debt	Deferred Long Term Liab
Total Assets		0.96	0.96	0.61	-0.49	-0.77	0.82	-0.05	0.88	0.93	-0.92	0.97	0.97	0.78	0.75	-0.85	0.78	0.75	-0.68	-0.67	-0.43
Total Stockholder Equity	0.96		1.0	0.51	-0.51	-0.83	0.66	-0.15	0.74	0.95	-0.99	1.0	0.92	0.82	0.68	-0.9	0.82	0.8	-0.82	-0.81	-0.47
Net Tangible Assets	0.96	1.0		0.48	-0.47	-0.85	0.65	-0.11	0.73	0.96	-0.99	1.0	0.91	0.85	0.65	-0.91	0.85	0.82	-0.84	-0.83	-0.51
Current Deferred Revenue	0.61	0.51	0.48		-0.82	-0.05	0.82	-0.63	0.76	0.39	-0.5	0.5	0.75	0.01	0.78	-0.21	0.01	-0.02	-0.02	-0.03	0.24
Net Debt	-0.49	-0.51	-0.47	-0.82		-0.03	-0.52	0.73	-0.44	-0.29	0.55	-0.47	-0.65	0.03	-0.84	0.14	0.03	0.07	0.12	0.09	-0.44
Retained Earnings	-0.77	-0.83	-0.85	-0.05	-0.03		-0.36	-0.29	-0.52	-0.91	0.8	-0.85	-0.64	-0.99	-0.23	0.97	-0.99	-0.99	0.93	0.92	0.79
Accounts Payable	0.82	0.66	0.65	0.82	-0.52	-0.36		-0.22	0.97	0.6	-0.6	0.68	0.87	0.37	0.79	-0.44	0.37	0.32	-0.16	-0.17	-0.23
Long Term Debt	-0.05	-0.15	-0.11	-0.63	0.73	-0.29	-0.22		-0.09	0.08	0.19	-0.11	-0.26	0.35	-0.38	-0.2	0.35	0.37	-0.09	-0.07	-0.38
Net Receivables	0.88	0.74	0.73	0.76	-0.44	-0.52	0.97	-0.09		0.72	-0.67	0.76	0.9	0.52	0.72	-0.6	0.52	0.48	-0.32	-0.32	-0.33
Good Will	0.93	0.95	0.96	0.39	-0.29	-0.91	0.6	0.08	0.72		-0.93	0.96	0.83	0.89	0.49	-0.97	0.89	0.88	-0.86	-0.87	-0.56
Total Liab	-0.92	-0.99	-0.99	-0.5	0.55	0.8	-0.6	0.19	-0.67	-0.93		-0.98	-0.89	-0.8	-0.67	0.88	-0.8	-0.77	0.84	0.83	0.41
Net Invested Capital	0.97	1.0	1.0	0.5	-0.47	-0.85	0.68	-0.11	0.76	0.96	-0.98		0.93	0.85	0.67	-0.91	0.85	0.82	-0.82	-0.82	-0.51
Total Current Assets	0.97	0.92	0.91	0.75	-0.65	-0.64	0.87	-0.26	0.9	0.83	-0.89	0.93		0.64	0.85	-0.73	0.64	0.61	-0.56	-0.55	-0.3
Capital Stock	0.78	0.82	0.85	0.01	0.03	-0.99	0.37	0.35	0.52	0.89	-0.8	0.85	0.64		0.28	-0.95	1.0	1.0	-0.9	-0.89	-0.79
Net Working Capital	0.75	0.68	0.65	0.78	-0.84	-0.23	0.79	-0.38	0.72	0.49	-0.67	0.67	0.85	0.28		-0.35	0.28	0.22	-0.2	-0.16	0.1
Intangible Assets	-0.85	-0.9	-0.91	-0.21	0.14	0.97	-0.44	-0.2	-0.6	-0.97	0.88	-0.91	-0.73	-0.95	-0.35		-0.95	-0.95	0.93	0.92	0.63
Common Stock	0.78	0.82	0.85	0.01	0.03	-0.99	0.37	0.35	0.52	0.89	-0.8	0.85	0.64	1.0	0.28	-0.95		1.0	-0.9	-0.89	-0.79
Property Plant Equipment	0.75	0.8	0.82	-0.02	0.07	-0.99	0.32	0.37	0.48	0.88	-0.77	0.82	0.61	1.0	0.22	-0.95	1.0		-0.91	-0.89	-0.78
Short Long Term Debt	-0.68	-0.82	-0.84	-0.02	0.12	0.93	-0.16	-0.09	-0.32	-0.86	0.84	-0.82	-0.56	-0.9	-0.2	0.93	-0.9	-0.91		0.99	0.61
Short Term Debt	-0.67	-0.81	-0.83	-0.03	0.09	0.92	-0.17	-0.07	-0.32	-0.87	0.83	-0.82	-0.55	-0.89	-0.16	0.92	-0.89	-0.89	0.99		0.65
Deferred Long Term Liab	-0.43	-0.47	-0.51	0.24	-0.44	0.79	-0.23	-0.38	-0.33	-0.56	0.41	-0.51	-0.3	-0.79	0.1	0.63	-0.79	-0.78	0.61	0.65

Click cells to compare fundamentals

Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).

Competition

Predict Biodesix

In accordance with the recently published financial statements, Biodesix has 15.18 M in Cash And Equivalents. This is 98.15% lower than that of the Biotechnology sector and 96.46% lower than that of the Health Care industry. The cash and equivalents for all United States stocks is 99.44% higher than that of the company.

Biodesix Cash And Equivalents Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biodesix's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biodesix could also be used in its relative valuation, which is a method of valuing Biodesix by comparing valuation metrics of similar companies.

Biodesix is currently under evaluation in cash and equivalents category among its peers.

Biodesix Fundamentals

	Return On Equity	-3.32
	Return On Asset	-0.23
	Profit Margin	(0.67) %
	Operating Margin	(0.47) %
	Current Valuation	258.93 M
	Shares Outstanding	145.47 M
	Shares Owned By Insiders	48.61 %
	Shares Owned By Institutions	42.82 %
	Number Of Shares Shorted	624.23 K
	Price To Book	8.20 X
	Price To Sales	3.48 X
	Revenue	49.09 M
	Gross Profit	24.06 M
	EBITDA	(37.1 M)
	Net Income	(52.15 M)
	Cash And Equivalents	15.18 M
	Cash Per Share	0.36 X
	Total Debt	60.69 M
	Debt To Equity	3.20 %
	Current Ratio	0.64 X
	Book Value Per Share	0.19 X
	Cash Flow From Operations	(22.87 M)
	Short Ratio	0.83 X
	Earnings Per Share	(0.37) X
	Target Price	3.1
	Number Of Employees	217
	Beta	1.21
	Market Capitalization	228.38 M
	Total Asset	99.1 M
	Retained Earnings	(419.57 M)
	Working Capital	6.27 M
	Net Asset	99.1 M

About Biodesix Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Biodesix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biodesix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biodesix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Biodesix Stock Analysis

When running Biodesix's price analysis, check to measure Biodesix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodesix is operating at the current time. Most of Biodesix's value examination focuses on studying past and present price action to predict the probability of Biodesix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodesix's price. Additionally, you may evaluate how the addition of Biodesix to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC